Trial Profile
Evaluation of the eFfect of early Initiation of secukinumab in systemic treatment-naïve patients with moderate to severe plaque psoriasis Requiring Systemic Treatment (FIRST)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jun 2019
Price :
$35
*
At a glance
- Drugs Secukinumab (Primary) ; Ciclosporin; Methotrexate
- Indications Plaque psoriasis
- Focus Pharmacokinetics
- Acronyms FIRST
- Sponsors Novartis Pharmaceuticals
- 13 Jun 2019 Status changed from recruiting to completed.
- 31 Mar 2017 New trial record